ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Prostate cancer study seeks hormone comeback after drug combo
Disease control OngoingThis study looks at whether testosterone levels return to normal after two years of treatment with relugolix and darolutamide in men with hormone-sensitive prostate cancer. About 33 participants will receive the drug combination and be monitored for testosterone recovery and side…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Atish Choudhury, MD • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New adaptive hormone therapy aims to outsmart advanced prostate cancer
Disease control OngoingThis study tests an adaptive approach to hormone therapy for men with stage IV prostate cancer that still responds to hormone treatment. The goal is to control the cancer while possibly reducing side effects by adjusting treatment based on how the cancer responds. Only 17 men par…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Shorter radiation for prostate cancer: same hormone therapy, fewer sessions?
Disease control OngoingThis study compares two types of radiation therapy for men with high-risk prostate cancer that has not spread. One group gets standard radiation (38 sessions over 8 weeks) and the other gets a shorter course (5 sessions over 5 weeks). Both groups also receive hormone therapy. The…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: CCTU • Aim: Disease control
Last updated May 18, 2026 12:08 UTC